AR004695A1 - NEUROTROPHIC COMPOUNDS AND COMPOSITIONS THAT HAVE AFFINITY WITH FKBP TYPE IMMUNOFILINS, AND APPLICATIONS OF THOSE. - Google Patents

NEUROTROPHIC COMPOUNDS AND COMPOSITIONS THAT HAVE AFFINITY WITH FKBP TYPE IMMUNOFILINS, AND APPLICATIONS OF THOSE.

Info

Publication number
AR004695A1
AR004695A1 ARP960104916A ARP960104916A AR004695A1 AR 004695 A1 AR004695 A1 AR 004695A1 AR P960104916 A ARP960104916 A AR P960104916A AR P960104916 A ARP960104916 A AR P960104916A AR 004695 A1 AR004695 A1 AR 004695A1
Authority
AR
Argentina
Prior art keywords
alkyl
cycloalkyl
alkenyl
group
furyl
Prior art date
Application number
ARP960104916A
Other languages
Spanish (es)
Original Assignee
Guilford William
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/650,461 external-priority patent/US5859031A/en
Application filed by Guilford William filed Critical Guilford William
Publication of AR004695A1 publication Critical patent/AR004695A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a compuestos de N-glioxil prolil ester neurotroficos que tienen afinidad con inmunofilinas del tipo FKBP, supreparación y uso como inhibidores de actividad de enzima relacionada con proteinas inmunofilinas,y particularmente inhibidores de actividad de enzimapeptidil-prolil isomerasa o rotamasa. Los compuestos poseen la formula general (I) donde R1 es un grupo de alquilo o alquenilo C1-C9 de cadena recta oramificada opcionalmente sustituido porcicloal quilo C3-C8, cicloalquilo C3 o C5, cicloalquenilo C5-C7, o Ar1 donde los mencionados grupos de alquilo,alquenilo cicloalquilo o cicloalquenilo pueden ser opcionalmente sustituidos por alquilo C1-C4, alquenilo C1-C4, o hidroxi, y dondeAr1 es sel eccionado delgrupo consistente de 1-naftilo, 2-naftilo, 2-indolilo, 3-indolilo, 2-furilo, 3-furilo, 2-tieniloL, 2-,3-, o 4-piridilo, o fenilo, teniendo 1 a 3sustituyentes; X es oxigeno o sulfuro; Y es oxigeno o NR2, donde R2 eshidrogeno o alquilo C1-C6; y Z es alquilo o alquenilo C2-C6 de cadena recta oramificada donde la cadena de alquilo es sustituida en una o mas posiciones por Ar1, segun definido arriba, cicloalquilo C3-C8, cicloalquilo conectado por unacadena dealquilo o alque nilo C1-C6 recta o no ramificada, o Ar2 donde Ar2 es seleccionado del grupo consistente de 2-indolilo, 3-indolilo, 2-furilo,3-furilo 2-tiazolilo, 2-tienilo, 3-tienilo, 2-, 3- o 4- piridilo, o fenilo, teniendo uno a tressustituyentes; Z también puede ser el fragmento (II) dondeR3 es seleccionado del grupo consistente de alquilo recto o ramificado C1-C8 opcionalmente sustituido por cicloalquilo C3-C8, o Ar1, conforme lo definidoarriba; X2 es ONR5,donde R5 esseleccionado del grupo consis tente en hidrogeno, alquilo y alquenilo C1-C6 recto o ramificado; R4 es seleccionado del grupoThe present invention relates to neurotrophic N-glyoxil prolyl ester compounds having affinity for FKBP-type immunophilins, their use and suppression as inhibitors of enzyme activity related to immunophilin proteins, and particularly inhibitors of enzyme activity peptidyl prolyl isomerase or rotamase. The compounds have the general formula (I) where R1 is a branched straight chain C1-C9 alkyl or alkenyl group optionally substituted by C3-C8 cycloalkyl, C3 or C5 cycloalkyl, C5-C7 cycloalkenyl, or Ar1 where said groups of alkyl, alkenyl, cycloalkyl or cycloalkenyl may optionally be substituted by C1-C4 alkyl, C1-C4 alkenyl, or hydroxy, and where Ar1 is selected from the group consisting of 1-naphthyl, 2-naphthyl, 2-indolyl, 2- furyl, 3-furyl, 2-thienylL, 2-, 3-, or 4-pyridyl, or phenyl, having 1 to 3 substituents; X is oxygen or sulfide; Y is oxygen or NR2, where R2 is hydrogen or C1-C6 alkyl; and Z is straight-chain oramified C2-C6 alkyl or alkenyl where the alkyl chain is substituted at one or more positions by Ar1, as defined above, C3-C8 cycloalkyl, cycloalkyl connected by a straight chain or C1-C6 alkenyl or unbranched, or Ar2 where Ar2 is selected from the group consisting of 2-indolyl, 3-indolyl, 2-furyl, 3-furyl 2-thiazolyl, 2-thienyl, 3-thienyl, 2-, 3- or 4- pyridyl, or phenyl, having one of three substituents; Z may also be fragment (II) where R3 is selected from the group consisting of C1-C8 straight or branched alkyl optionally substituted by C3-C8 cycloalkyl, or Ar1, as defined above; X2 is ONR5, where R5 is selected from the group consisting of hydrogen, C1-C6 straight or branched alkyl and alkenyl; R4 is selected from the group

ARP960104916A 1996-05-21 1996-10-25 NEUROTROPHIC COMPOUNDS AND COMPOSITIONS THAT HAVE AFFINITY WITH FKBP TYPE IMMUNOFILINS, AND APPLICATIONS OF THOSE. AR004695A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/650,461 US5859031A (en) 1995-06-07 1996-05-21 Small molecule inhibitors of rotamase enzyme activity

Publications (1)

Publication Number Publication Date
AR004695A1 true AR004695A1 (en) 1999-03-10

Family

ID=24609008

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP960104916A AR004695A1 (en) 1996-05-21 1996-10-25 NEUROTROPHIC COMPOUNDS AND COMPOSITIONS THAT HAVE AFFINITY WITH FKBP TYPE IMMUNOFILINS, AND APPLICATIONS OF THOSE.
ARP010104365A AR030740A2 (en) 1996-05-21 2001-09-14 A COMPOUND DERIVED FROM N-GLIOXYLPROLINE AND A METHOD TO PREPARE IT
ARP010104364A AR030739A2 (en) 1996-05-21 2001-09-14 A NON-IMMUNOSUPRESSIVE COMPOUND DERIVED FROM N-GLIOXYLPROLINE, A METHOD TO PREPARE IT AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND IT

Family Applications After (2)

Application Number Title Priority Date Filing Date
ARP010104365A AR030740A2 (en) 1996-05-21 2001-09-14 A COMPOUND DERIVED FROM N-GLIOXYLPROLINE AND A METHOD TO PREPARE IT
ARP010104364A AR030739A2 (en) 1996-05-21 2001-09-14 A NON-IMMUNOSUPRESSIVE COMPOUND DERIVED FROM N-GLIOXYLPROLINE, A METHOD TO PREPARE IT AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND IT

Country Status (4)

Country Link
AR (3) AR004695A1 (en)
ID (1) ID16707A (en)
TW (2) TWI252226B (en)
ZA (1) ZA968983B (en)

Also Published As

Publication number Publication date
TWI252226B (en) 2006-04-01
ID16707A (en) 1997-11-06
TW453992B (en) 2001-09-11
ZA968983B (en) 1998-07-27
AR030740A2 (en) 2003-09-03
AR030739A2 (en) 2003-09-03

Similar Documents

Publication Publication Date Title
AR036391A1 (en) USE OF A PROSTAGLANDINE COMPOSITE TO PREPARE A PHARMACEUTICAL COMPOSITION TO OPEN CIC CHANNELS IN A MAMMER AND PROSTAGLANDINE COMPOUNDS
AR041303A1 (en) N-SUBSTITUTED PIPERIDINIL-IMIDAZOPIRIDINE COMPOUNDS AS 5-HT4 "RECEIVER MODULATORS
NO20091704L (en) Inhibitors of hepatitis C virus
EA200601830A1 (en) ORT-SUBSTITUTED ARYL OR HETEROARYL AMIDAL COMPOUNDS
AR011882A1 (en) DERIVATIVES OF N-OXIDES OF ESTERS, AMIDES, THIOESTERS AND HETERO CYCLIC KETONES, PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOUND.
ECSP066968A (en) METHYL-ARIL OR HETEROARIL-AMIDA SUBSTITUTED COMPOUNDS
NO20062267L (en) Hepatitis C virus inhibitors
CR5720A (en) METHOD FOR USING NEUROTROPHIC SULFANAMID COMPOUNDS
AR011320A1 (en) SULFONAMIDE COMPOUND LINKED WITH HETERO-CYCLIC THIOESTER N, PHARMACEUTICALLY ACCEPTABLE COMPOSITION, USE OF THE COMPOUND AND PROCESSES FOR LAPREPARATION OF THE COMPOUND
BRPI0518642A2 (en) 12-aryl prostaglandin analogs
EA201101240A1 (en) HEPATITIS C VIRUS INHIBITORS
EA200100992A1 (en) IMPDH ENZYME INHIBITORS
CO6331337A2 (en) 5-SUBSTITUTED ISOINDOL COMPOUNDS
PE20130281A1 (en) DERIVATIVES OF 5-ALKINYL-3-AMIDE-2-THIOPHENE-CARBOXYL ACID AS INHIBITORS OF FLAVIVIRIDAE VIRUS
EA201070782A1 (en) OXADIAZOLE DERIVATIVES, ACTIVE WITH RESPECT TO Sphinhosin-1-phosphate (SIP)
RS51743B (en) Macrocyclic inhibitors of hepatitis c virus
ECSP099269A (en) FENILUREA COMPOUNDS AS SOLUBLE HYDROLASE EPOXIDE INHIBITORS
NO20091706L (en) Inhibitors of hepatitis C virus
AR118724A1 (en) DIHYDROOROTATE DEHYDROGENASE INHIBITORS
DK1313721T3 (en) Non-imidazole aryloxyalkylamines as H3 receptor ligands
HK1051712A1 (en) Acidic treatment liquid and method of treating copper surfaces.
PE20071225A1 (en) PIPERIDINE-DERIVED COMPOUNDS AS INHIBITORS OF NEUROCININ-1 (NK-1) AND OF THE SEROTONIN TRANSPORTER
CO6321159A2 (en) USED FUSIONED PIRAZINE COMPOUNDS FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
TNSN07439A1 (en) Derivatives of,4,5 - diarylpyrrole, preparation method thereof and use of same in therapeutics
AR004695A1 (en) NEUROTROPHIC COMPOUNDS AND COMPOSITIONS THAT HAVE AFFINITY WITH FKBP TYPE IMMUNOFILINS, AND APPLICATIONS OF THOSE.

Legal Events

Date Code Title Description
FB Suspension of granting procedure